Skip to main content
. 2022 Jan-Apr;16(1):65–70. doi: 10.5005/jp-journals-10078-1359

Table 2.

BCVA at final visit in HSV, HZV, CMV keratouveitis

BCVA (in LogMAR) HSV HZV CMV Total p-value
20/20 - 20/40 (0-0.3) 18 5 2 25 0.774
20/50 - 20/200 (0.4-1) 19 3 22
CF-PL (1.3-2.5) 6 1 7
NPL4 1 1
Total 44 9 2 55